Medplus Health Services enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


7,180	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
227	198	86.1	91.2	228
−0.7	−0.7	−0.7	−0.6	−0.7
6,952	—	—	—	—
−227	−198	−86.1	−91.2	−228
₹579.07	—	—	—	—

2,068	1,975	1,740	1,577	1,491

0.92×	—	—	—	—
11.02×	—	—	—	—
21.68×	—	—	—	—
18.66×	—	—	—	—
7,587	6,892	6,136	5,625	4,558
631	607	487	354	266
321	324	237	130	84.1
—	496	540	144	90.4
373	373	481	59.3	−78.6
—	373	462	49.0	−78.6
—	123	59.5	84.4	169

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services

₹ CrorePeersAPOLLOHOSP MANYAVAR MSTCLTD NESCO JUSTDIAL JSLL QUESS IXIGOMcap ₹7,180 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	7,179.9
- Cash, Equiv & ST Investments	228.4	91.2	86.1	198.4	227.1
+ Minority Interest	-0.7	-0.6	-0.7	-0.7	-0.7
Enterprise Value	—	—	—	—	6,952.0
Net Debt (memo)	-228.4	-91.2	-86.1	-198.4	-227.1
EV per Share	—	—	—	—	579.07

Total Capital	1,490.5	1,577.4	1,739.9	1,974.7	2,067.6

EV/Sales	—	—	—	—	0.92
EV/EBITDA	—	—	—	—	11.02
EV/EBIT	—	—	—	—	21.68
EV/Free Cash Flow	—	—	—	—	18.66
Reference Items — Trailing FY Values
Sales	4,557.6	5,624.9	6,136.1	6,892.5	7,587.2
EBITDA	265.7	354.1	487.1	607.4	631.1
EBIT	84.1	129.9	237.3	324.5	320.6
Operating Cash Flow	90.4	143.7	540.4	495.6	—
Free Cash Flow	-78.6	59.3	481.0	372.6	372.6
FCFF (free cash flow to the firm)	-78.6	49.0	462.5	372.5	—
Capital Expenditure	169.0	84.4	59.5	123.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.